Get the Stockscreener App
1.00
2.35%
0.023
After Hours:
.99
-0.01
-1.00%
Werewolf Therapeutics Inc stock is traded at $1.00, with a volume of 170.25K.
It is up +2.35% in the last 24 hours and down -38.27% over the past month.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
See More
Previous Close:
$0.977
Open:
$0.9769
24h Volume:
170.25K
Relative Volume:
0.20
Market Cap:
$48.54M
Revenue:
$19.94M
Net Income/Loss:
$-37.37M
P/E Ratio:
-0.9615
EPS:
-1.04
Net Cash Flow:
$-33.38M
1W Performance:
+14.52%
1M Performance:
-38.27%
6M Performance:
-18.03%
1Y Performance:
-49.24%
1-Day Range:
$0.968
$1.02
1-Week Range:
$0.8733
$1.03
52-Week Range:
$0.595
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Name
Werewolf Therapeutics Inc
Sector
Industry
Phone
617-952-0555
Address
200 TALCOTT AVENUE, WATERTOWN
Compare HOWL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.00 | 47.42M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Aug-24-23 | Initiated | Wedbush | Outperform |
| Jun-06-23 | Resumed | Jefferies | Buy |
| Sep-10-21 | Initiated | BofA Securities | Buy |
| May-25-21 | Initiated | Evercore ISI | Outperform |
| May-25-21 | Initiated | H.C. Wainwright | Buy |
| May-25-21 | Initiated | Jefferies | Buy |
| May-25-21 | Initiated | SVB Leerink | Outperform |
View All
Werewolf Therapeutics Inc Stock (HOWL) Latest News
Aug Mood: Is Werewolf Therapeutics Inc. stock ready for breakoutWeekly Trade Recap & Daily Technical Stock Forecast Reports - moha.gov.vn
Why retail investors pile into Werewolf Therapeutics Inc. stockBreakout Watch & Verified Momentum Watchlists - moha.gov.vn
Werewolf Therapeutics (HOWL) 10% owners sell $179k in stock By Investing.com - Investing.com Australia
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $115k By Investing.com - Investing.com South Africa
MPM BioVentures sells Werewolf Therapeutics (HOWL) shares for $179k By Investing.com - Investing.com Nigeria
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $115k - Investing.com
MPM BioVentures sells Werewolf Therapeutics (HOWL) shares for $179k - Investing.com
Werewolf Therapeutics (HOWL) 10% owners sell $179k in stock - Investing.com India
A Look at Werewolf Therapeutics Inc (HOWL) Shares in the Recent Past Indicates Growth - Setenews
Head-To-Head Contrast: Werewolf Therapeutics (NASDAQ:HOWL) versus X4 Pharmaceuticals (NASDAQ:XFOR) - Defense World
Werewolf Therapeutics (HOWL) 10% owner sells $147,912 in stock By Investing.com - Investing.com Australia
Werewolf Therapeutics (HOWL) 10% owner sells $147,912 in stock - Investing.com
Chmn Evnin Sells 102,753 ($94.9K) Of Werewolf Therapeutics Inc [HOWL] - TradingView
[Form 4] Werewolf Therapeutics, Inc. Insider Trading Activity - Stock Titan
Predicting Werewolf Therapeutics Inc. trend using moving averagesJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Werewolf Therapeutics Inc. stock trend forecastEarnings Trend Report & Low Risk Entry Point Tips - newser.com
Werewolf Therapeutics (NASDAQ:HOWL) Price Target Cut to $7.00 by Analysts at Bank of America - Defense World
What MACD signals say about Werewolf Therapeutics Inc.Portfolio Performance Report & High Return Trade Guides - newser.com
B of A Securities Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - Nasdaq
Werewolf therapeutics (HOWL) sees $200k+ in sales by MPM related entities - Investing.com South Africa
Evnin Luke sells Werewolf Therapeutics (HOWL) shares worth $128k By Investing.com - Investing.com Nigeria
Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $200,665 By Investing.com - Investing.com Nigeria
Evnin Luke sells Werewolf Therapeutics (HOWL) shares worth $128k - Investing.com
Owner Gadicke Sells 209,652 ($200.7K) Of Werewolf Therapeutics Inc [HOWL] - TradingView
Owner MPM Asset Management Investors BV2014 LLC Files To Sell 4,479 Of Werewolf Therapeutics Inc [HOWL] - TradingView
Owner MPM Asset Management LLC Files To Sell 20,597 Of Werewolf Therapeutics Inc [HOWL] - TradingView
Views of Wall Street’s Leading Experts on Werewolf Therapeutics Inc - Setenews
Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $200,665 - Investing.com
Will Werewolf Therapeutics Inc. price bounce be sustainableRisk Management & Free Community Consensus Stock Picks - newser.com
How Werewolf Therapeutics Inc. stock performs after earningsSwing Trade & Daily Price Action Insights - newser.com
Why Werewolf Therapeutics Inc. stock is rated strong buyMarket Sentiment Report & Trade Opportunity Analysis Reports - Fundação Cultural do Pará
Werewolf Therapeutics Inc. stock trendline breakdown2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Werewolf Therapeutics’ Promising Study on WTX-124 in Cancer Treatment - MSN
Will Werewolf Therapeutics Inc. stock recover faster than marketFed Meeting & Low Drawdown Trading Techniques - newser.com
Advanced analytics toolkit walkthrough for Werewolf Therapeutics Inc.Market Growth Summary & Precise Swing Trade Alerts - newser.com
Evnin Luke, director at Werewolf Therapeutics, sells $154k in HOWL By Investing.com - Investing.com South Africa
Werewolf Therapeutics (HOWL) 10% owners sell $241k in stock By Investing.com - Investing.com Nigeria
Mpm Bioventures sells Werewolf Therapeutics (HOWL) shares for $241k By Investing.com - Investing.com UK
Werewolf Therapeutics Inc Stock (HOWL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):